A detailed history of Vital Stone Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Vital Stone Financial, LLC holds 236 shares of ABBV stock, worth $42,010. This represents 0.03% of its overall portfolio holdings.

Number of Shares
236
Previous 234 0.85%
Holding current value
$42,010
Previous $40,000 15.0%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $327 - $398
2 Added 0.85%
236 $46,000
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $309 - $361
2 Added 0.86%
234 $40,000
Q3 2023

Nov 15, 2023

SELL
$133.59 - $154.65 $1,335 - $1,546
-10 Reduced 4.13%
232 $32,000
Q2 2023

Aug 21, 2023

BUY
$132.51 - $164.9 $21,996 - $27,373
166 Added 218.42%
242 $39,000
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $22,559 - $25,980
-156 Reduced 67.24%
76 $10,000
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $32,087 - $38,481
232 New
232 $37 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.